Tiosano, L
Segal, O
Mathalone, N
Pollack, A
Ehrlich, R
Klemperer, I
Barak, Y
Moroz, I
Chowers, I
Goldstein, M
Article History
Received: 26 May 2016
Accepted: 5 December 2016
First Online: 17 February 2017
Competing interests
: Dr Chowers serves as consultant for Lycored, Biokine, Bayer, and Novartis; Dr Goldstein serves as a consultant and invited lecturer for Novartis, Allergan, and Bayer; and Dr Polack serves as a consulted for Allergan and Bayer. The remaining authors declare no conflict of interest.